Minocycline: therapeutic potential in psychiatryPEGylation of Interferon-β-1aLong-Term Outcomes with Medications for Attention-Deficit Hyperactivity DisorderGene therapy in Parkinson's disease: rationale and current statusTumour Necrosis Factor Modulation for Treatment of Alzheimerʼs DiseaseEfficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and AdultsThirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.Methylphenidate and its IsomersMechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of SchizophreniaAttention-Deficit Hyperactivity Disorder in GirlsProspects for Improving Brain Function in Individuals with Down SyndromeOverdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and ManagementRole of Infection in the Pathogenesis of Alzheimerʼs DiseaseWithdrawing Benzodiazepines in Primary CareDelirium and its TreatmentPharmacological Control of Acute AgitationDiagnosis and Treatment of Agoraphobia with Panic DisorderPsychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.ClozapineCognitive Effects of Long-Term Benzodiazepine UseDrug-Induced Behavioural DisinhibitionIntranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidenceEnhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the networkCalcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migrainePharmacotherapy for cannabis dependence: how close are we?Identifying and Managing Pain in People with Alzheimer's Disease and Other Types of Dementia: A Systematic Review.Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and ManagementAntiepileptic Drug Treatment in Children with EpilepsyPropofol: a review of its role in pediatric anesthesia and sedationSphingosine 1-phosphate receptor modulators in multiple sclerosisCan antipsychotics improve social cognition in patients with schizophrenia?A comprehensive review of rapid-onset opioids for breakthrough painKetamine for treatment-resistant unipolar depression: current evidenceNeuroprotective properties of citicoline: facts, doubts and unresolved issuesDeveloping Medications Targeting Glutamatergic Dysfunction in Autism: Progress to DateEfficacy and safety of intravenous valproate for status epilepticus: a systematic reviewThe Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewSynaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and BeyondTeriflunomide in Patients with Relapsing-Remitting Forms of Multiple SclerosisThe Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
P1433
Q22241418-F44DADAA-7602-4D67-A3B3-E60ECEC93920Q22241420-C119F8A1-615F-4F37-9BAC-8BF75AEBC3C6Q22241421-4EE47CFC-26E8-4FFF-B6B6-3205DA7C7621Q22241423-6D89B221-7FDE-4F34-8231-0ED47437F04CQ22241425-12043CDC-65B9-4D69-9162-99DECCBC3C22Q22241427-4AD7AF34-9786-4510-99E6-6D108ADE0413Q22241428-BAA23E30-BAFA-4DC3-B3C2-BA880119110CQ22241429-C017CAAE-97C1-44DC-8840-892546344CD0Q22241430-B696A41F-B7B5-4934-B906-5F85D28472F2Q22241431-8EFC2DB4-AF3E-44A0-96FC-03D50CE9CDD9Q22252566-98655FE9-3C43-4901-BFD2-395C5030B2A7Q22252568-D72DD10D-DA24-4D93-B192-5230F0027FB1Q22305814-BB37E64E-987A-4DC3-9E3E-799E036EE07CQ22305817-EB3307D7-2A5D-418B-87E6-60351437D66CQ22305822-8A812E0C-E75D-44F0-92D3-56616187BFFCQ22305825-6B1455C2-1031-4882-BBFD-2A8303AB5054Q22305826-767C2142-1076-4660-A04D-7753FEB71267Q22305827-5D27D60A-1330-4FBA-831B-A6C0A73DCBE0Q22305828-F12004E5-465A-418C-B567-5DF02DC11DCFQ22305829-ACD4FEE6-4E95-4A97-A34A-5964BE6BA94FQ22305831-7E269B40-066B-4818-B5C5-85FFEFB34973Q24601034-B731B205-5C10-4B18-AEC0-947A4D7890DBQ24630696-648D3124-6E81-4ECC-A830-BD3E48CE36AAQ24632671-99B19A12-86E9-49B6-85C4-C20FEA8431C1Q24648976-41DE0CD4-62A1-43C3-BD23-CFCE9B215EE0Q26744776-86C2C5E7-F38D-4DC9-95A9-404CA143EBE1Q26751458-9DDD41B2-A629-4E12-85DA-E4CE14BF1699Q26781771-834F336E-A8E1-482D-832C-3251A2C0A8DEQ26796361-8904D907-0CDD-4A51-9543-CECB12CC8756Q26799440-46B22803-9F5C-4E2C-A36B-477204E2D05EQ26822977-8BE29B52-D3AD-41A8-AAB8-FEC15F236E6BQ26862553-ED8DB060-241A-4B36-AB54-192CE0876420Q27004508-41F3F723-4323-4E1F-ADD8-02CC607CAB50Q27021189-3B1E5BA0-A7F8-4DF6-9C3F-11857EEEDCECQ27025683-635C89F5-AE97-43C6-9F24-68B287A4FEDDQ27025704-8A86FDD0-1484-47BA-BC5D-6C9979A1D96CQ28066725-2F093995-F3FC-4104-AF65-407E3A4412E1Q28068507-13F9436D-57A8-4191-ADDD-310A540FC8ECQ28070118-FB3E07EC-05A0-492D-A66C-B6A53383D714Q28073377-775A6B2D-C23B-4BB7-80B2-519325690576
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Adis, Springer Healthcare
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
C N S Drugs
@da
CNS Drugs
@ast
CNS Drugs
@de
CNS Drugs
@en
CNS Drugs
@es
CNS Drugs
@fi
CNS Drugs
@fr
CNS Drugs
@it
CNS Drugs
@nb
CNS Drugs
@nl
type
label
C N S Drugs
@da
CNS Drugs
@ast
CNS Drugs
@de
CNS Drugs
@en
CNS Drugs
@es
CNS Drugs
@fi
CNS Drugs
@fr
CNS Drugs
@it
CNS Drugs
@nb
CNS Drugs
@nl
prefLabel
C N S Drugs
@da
CNS Drugs
@ast
CNS Drugs
@de
CNS Drugs
@en
CNS Drugs
@es
CNS Drugs
@fi
CNS Drugs
@fr
CNS Drugs
@it
CNS Drugs
@nb
CNS Drugs
@nl
P243
P3181
P1055
P1058
P1156
P1160
P1277
P1476
CNS Drugs
@en
P236
P243
P3181
P407
P495
P571
1995-01-01T00:00:00Z